115 related articles for article (PubMed ID: 33830800)
1. Adapting a 2-week-wait colorectal service in the pandemic using the quantitative faecal immunochemical test.
Cock K; Bromley R; Faux W
Br J Nurs; 2021 Apr; 30(7):404-408. PubMed ID: 33830800
[TBL] [Abstract][Full Text] [Related]
2. Adoption of faecal immunochemical testing for 2-week-wait colorectal patients during the COVID-19 pandemic: an observational cohort study reporting a new service at a regional centre.
Maclean W; Limb C; Mackenzie P; Whyte MB; Benton SC; Rockall T; Jourdan I
Colorectal Dis; 2021 Jul; 23(7):1622-1629. PubMed ID: 33068489
[TBL] [Abstract][Full Text] [Related]
3. Is qFIT a useful tool in prioritising symptomatic patients referred with suspect colorectal cancer in the COVID-19 era?
Small S; Coulson R; Spence R; McAllister I
Ulster Med J; 2022 May; 91(2):79-84. PubMed ID: 35722213
[TBL] [Abstract][Full Text] [Related]
4. Developing a prioritization model for endoscopy and colorectal cancer 2-week wait referrals during the COVID-19 pandemic-is faecal immunochemical testing the answer?
Habib Bedwani N; English W; Coda S; Akinlade F; Elzayat I; Seward EW; Hayee B; Hanson M; Banerjee S
Br J Surg; 2021 Jan; 108(1):e18-e19. PubMed ID: 33640923
[TBL] [Abstract][Full Text] [Related]
5. Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing.
Maeda Y; Gray E; Figueroa JD; Hall PS; Weller D; Dunlop MG; Din FVN
BJS Open; 2021 Jul; 5(4):. PubMed ID: 34228096
[TBL] [Abstract][Full Text] [Related]
6. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
[TBL] [Abstract][Full Text] [Related]
7. Short-term outcomes of a COVID-adapted triage pathway for colorectal cancer detection.
Miller J; Maeda Y; Au S; Gunn F; Porteous L; Pattenden R; MacLean P; Noble CL; Glancy S; Dunlop MG; Din FVN
Colorectal Dis; 2021 Jul; 23(7):1639-1648. PubMed ID: 33682302
[TBL] [Abstract][Full Text] [Related]
8. An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.
Rodríguez-Alonso L; Rodríguez-Moranta F; Ruiz-Cerulla A; Lobatón T; Arajol C; Binefa G; Moreno V; Guardiola J
Dig Liver Dis; 2015 Sep; 47(9):797-804. PubMed ID: 26055489
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer referrals during the COVID-19 pandemic: the utility of CT and faecal immunochemical testing.
Tolley T; Whewell H; Davies DR; Codd RJ; Swarnkar KJ; Williams GL
Br J Surg; 2021 Apr; 108(3):e119-e120. PubMed ID: 33793747
[No Abstract] [Full Text] [Related]
10. The Direct Access Colonoscopy Clinic: Improving time to colonoscopy for eligible positive faecal occult blood test patients in Broken Hill NSW.
Whitelaw L; Hammond K; Cumming M; Mansfield K; Saurman E
Aust J Rural Health; 2020 Feb; 28(1):81-86. PubMed ID: 31650635
[TBL] [Abstract][Full Text] [Related]
11. Referral letters for 2-week wait suspected colorectal cancer do not allow a 'straight-to-test' pathway.
Aljarabah MM; Borley NR; Goodman AJ; Wheeler JM
Ann R Coll Surg Engl; 2009 Mar; 91(2):106-9. PubMed ID: 19102819
[TBL] [Abstract][Full Text] [Related]
12. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.
Nicholson BD; James T; Paddon M; Justice S; Oke JL; East JE; Shine B
Aliment Pharmacol Ther; 2020 Sep; 52(6):1031-1041. PubMed ID: 32677733
[TBL] [Abstract][Full Text] [Related]
13. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.
Pin Vieito N; Zarraquiños S; Cubiella J
World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909
[TBL] [Abstract][Full Text] [Related]
14. The misuse of the faecal occult blood test under the lower gastrointestinal two week wait rule.
Shaw AG; Lund JN; Longman C; Tierney GM; Goddard AF
Colorectal Dis; 2009 Jan; 11(1):94-6. PubMed ID: 18462248
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy.
Tsapournas G; Hellström PM; Cao Y; Olsson LI
Scand J Gastroenterol; 2020 Feb; 55(2):184-192. PubMed ID: 31906738
[No Abstract] [Full Text] [Related]
16. The diagnostic accuracy of the faecal immunochemical test for colorectal cancer in risk-stratified symptomatic patients.
D'Souza N; Hicks G; Benton SC; Abulafi M
Ann R Coll Surg Engl; 2020 Mar; 102(3):174-179. PubMed ID: 31697171
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of the '2-week wait' referral service for colorectal cancer.
Leung E; Grainger J; Bandla N; Wong L
Int J Clin Pract; 2010 Nov; 64(12):1671-4. PubMed ID: 20946272
[TBL] [Abstract][Full Text] [Related]
18. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
19. Patient satisfaction with clinicians in colorectal 2-week wait clinics.
Cock K; Kent B
Br J Nurs; 2017 Mar; 26(6):319-323. PubMed ID: 28345973
[TBL] [Abstract][Full Text] [Related]
20. Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: Concepts and challenges.
Fraser CG
Surgeon; 2018 Oct; 16(5):302-308. PubMed ID: 29548552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
